HBIO (STOCKS)
Harvard Bioscience Inc
$5.900000
-0.180000 (-2.96%)
Prev close: $6.080000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- John D. Duke
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $27.22M
- Employees
- 355
- P/E (TTM)
- -2.73
- P/B (TTM)
- 2.73
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
4
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.33 | $-0.63 | +0.3024 | +47.82% |
|
Dec 2025 (Q4)
|
$0.00 | $0.36 | -0.3570 | -100.00% |
|
Sep 2025 (Q3)
|
$0.00 | $0.05 | -0.0510 | -100.00% |
|
Jun 2025 (Q2)
|
$-0.10 | $-0.10 | +0.0020 | +1.96% |
Financial Statements
| Revenues | $85.53M |
| Benefits Costs and Expenses | $95.43M |
| Cost Of Revenue | $35.56M |
| Costs And Expenses | $95.43M |
| Gross Profit | $49.97M |
| Nonoperating Income/Loss | -$9.81M |
| Operating Expenses | $50.06M |
| Research and Development | $8.83M |
| Other Operating Expenses | $41.23M |
| Operating Income/Loss | -$86.00K |
| Income/Loss From Continuing Operations After Tax | -$9.78M |
| Income/Loss From Continuing Operations Before Tax | -$9.90M |
| Income Tax Expense/Benefit | -$115.00K |
| Net Income/Loss | -$9.78M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$9.78M |
| Net Income/Loss Available To Common Stockholders, Basic | -$9.78M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.91 |
| Diluted Earnings Per Share | -$0.91 |
| Basic Average Shares | 93,403,000 |
| Diluted Average Shares | 93,403,000 |
| Assets | $77.94M |
| Current Assets | $47.48M |
| Inventory | $22.21M |
| Other Current Assets | $25.27M |
| Noncurrent Assets | $30.46M |
| Fixed Assets | $4.87M |
| Intangible Assets | $6.91M |
| Other Non-current Assets | $18.68M |
| Liabilities | $67.89M |
| Current Liabilities | $23.86M |
| Accounts Payable | $5.29M |
| Wages | $2.18M |
| Other Current Liabilities | $16.40M |
| Noncurrent Liabilities | $44.03M |
| Long-term Debt | $36.21M |
| Other Non-current Liabilities | $7.82M |
| Equity | $10.05M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $10.05M |
| Liabilities And Equity | $77.94M |
| Net Cash Flow From Operating Activities | $3.08M |
| Net Cash Flow From Operating Activities, Continuing | $3.08M |
| Net Cash Flow From Investing Activities | -$1.80M |
| Net Cash Flow From Investing Activities, Continuing | -$1.80M |
| Net Cash Flow From Financing Activities | -$96.00K |
| Net Cash Flow From Financing Activities, Continuing | -$96.00K |
| Net Cash Flow | $1.19M |
| Net Cash Flow, Continuing | $1.19M |
| Comprehensive Income/Loss | -$7.74M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$7.74M |
| Other Comprehensive Income/Loss | $2.05M |